{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:53:58Z","timestamp":1780649638283,"version":"3.54.1"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Acromegaly is a rare condition typically caused by benign pituitary adenomas, resulting in excessive production of growth hormone. Clinical manifestations of acromegaly are diverse, varying from the overgrowth of body tissue to cardiovascular, metabolic, and osteoarticular disorders. Symptoms may emerge slowly, overlapping with other diseases and often involve many different healthcare specialists. In the last decade, efforts to provide an accurate and timely diagnosis of acromegaly have improved disease management and clinical experience. Despite this progress, marked differences in the diagnosis, treatment, and management of acromegaly exist from country-to-country. To address these inconsistencies in the region comprising Central and Eastern Europe, Israel, and Kazakhstan, a panel of acromegaly experts from 13 of these countries was convened. Acromegaly experts from each country provided available information on the approaches from their country, including regional treatment centers and multidisciplinary teams, treatment access, reimbursement and availability, and physician education, disease awareness, and patient advocacy. Across several areas of acromegaly management, divergent approaches were identified and discussed, including the provision of multidisciplinary care, approved and available treatments, and disease awareness programs. These were recognized as areas of potential improvement in the management of acromegaly, in addition to participation in national and regional acromegaly registries. Further experience exchange will facilitate the identification of specific strategies that can be adapted in each country, and widespread participation in acromegaly registries will enable their evaluation. It is anticipated that this approach will support the optimization of acromegaly patient care across this region.<\/jats:p>","DOI":"10.3389\/fendo.2022.816426","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T07:36:25Z","timestamp":1645515385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan"],"prefix":"10.3389","volume":"13","author":[{"given":"Marek","family":"Bolanowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Doknic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mykola","family":"Guk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"H\u00e1na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Ilovayskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Kastelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaz","family":"Kocjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ku\u017ema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akmaral","family":"Nurbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Poiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolette","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vandeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Paidac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Simoneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National Acromegaly Registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1764-4","article-title":"Signs and Symptoms of Acromegaly at Diagnosis: The Physician's and the Patient's Perspectives in the ACRO-POLIS Study","volume":"63","author":"Caron","year":"2019","journal-title":"Endocrine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at Diagnosis in 3173 Patients From the Liege Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B5","first-page":"i1","article-title":"Symptoms and Sign of Active Acromegaly in Patients From Moscow Region","volume-title":"Endocrine Society\u2019s 96th Annual Meeting and Expo","author":"Dreval","year":"2014"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21856\/j-PEP.2019.2.17","article-title":"Clinical and Hormonal Features of Acromegaly in Patients From a Ukrainian Neuroendocrinology Centre","volume":"68","author":"Khyzhnyak","year":"2019","journal-title":"Prob Endocr Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.21856\/j-PEP.2021.1.06","article-title":"Acromegaly Combined With Gigantism Associated With the AIP-Gene Mutation: A Clinical Case","volume":"75","author":"Nikolaiev","year":"2021","journal-title":"Problems Endocrine Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12959","article-title":"ACROSCORE: A New and Simple Tool for the Diagnosis of Acromegaly, a Rare and Underdiagnosed Disease","volume":"84","author":"Prencipe","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.14341\/probl12699","article-title":"Selective Screening of Patients With Associated Somatic Diseases as a Method of Early Detection of Acromegaly","volume":"67","author":"Antsiferov","year":"2021","journal-title":"Probl Endokrinol (Mosk)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","article-title":"A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update","volume":"105","author":"Giustina","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-1022","article-title":"Could Different Treatment Approaches in Acromegaly Influence Life Expectancy? A Comparative Study Between Bulgaria and Campania (Italy)","volume":"171","author":"Colao","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.642131","article-title":"Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center","volume":"12","author":"Rolla","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2020.0050","article-title":"Therapeutic Effect of Presurgical Treatment With Longacting Octreotide (Sandostatin\u00ae LAR\u00ae) in Patients With Acromegaly","volume":"71","author":"Bolanowski","year":"2020","journal-title":"Endokrynol Pol"},{"key":"B14","first-page":"i1","article-title":"Gender Differences in Thyroid Abnormalities at Patients With Acromegaly: SAT-748","volume-title":"The Endocrine Society\u2019s 94th Annual Meeting and Expo","author":"Shestakova","year":"2012"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EC-14-0021","article-title":"Prevalence of Diabetes Mellitus in Patients With Acromegaly","volume":"3","author":"Dreval","year":"2014","journal-title":"Endocr Connect"},{"key":"B16","first-page":"29","article-title":"The Prevalence of Benign and Malignant Neoplasms in Acromegalic Patients","volume":"61","author":"Baldys-Waligorska","year":"2010","journal-title":"Endokrynol Pol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.18786\/2072-0505-2014-32-36-42","article-title":"Prevalence of Sleep Disordered Breathing in Patients With Newly Diagnosed Acromegaly","volume":"32","author":"Tsoy","year":"2014","journal-title":"Almanac Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.18786\/2072-0505-2014-31-29-33","article-title":"Background Changes of the Digestive System Mucosa in Patients With Acromegaly","volume":"31","author":"Titaeva","year":"2014","journal-title":"Almanac Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.26442\/terarkh2018901065-70","article-title":"Prevalence and Risk Factors of Sleep Breathing Disorders in Patients With Acromegaly From Moscow Region","volume":"90","author":"Kovaleva","year":"2018","journal-title":"Ter Arkh"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.32.P612","article-title":"Menstrual Function in Women of Reproductive Age With Acromegaly","volume":"32","author":"Dreval","year":"2013","journal-title":"Endocrine Abstracts"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.0014","article-title":"New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria","volume":"8","author":"Kamusheva","year":"2020","journal-title":"Front Public Health"},{"key":"B22","article-title":"Abnormalities in Glucose Homeostasis in Acromegaly. Does the Prevalence of Glucose Intolerance Depend on the Level of Activity of the Disease and the Duration of the Symptoms","volume":"60","author":"Stelmachowska-Banas","year":"2009","journal-title":"Endokrynol Pol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3275\/7858","article-title":"Clinical Features and Therapeutic Outcomes of Patients With Acromegaly: Single-Center Experience","volume":"34","author":"Dusek","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the Management and Comorbidities of Acromegaly Over Three Decades: The French Acromegaly Registry","volume":"176","author":"Maione","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0881","article-title":"Non-Invasive DXA-Derived Bone Structure Assessment of Acromegaly Patients: A Cross-Sectional Study","volume":"180","author":"Kuzma","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective Study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab259","article-title":"Vertebral Fractures Occur Despite Control of Acromegaly and are Predicted by Cortical Volumetric Bone Mineral Density","volume":"106","author":"Kuzma","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2007.03.103","article-title":"Bone Properties in Patients With Acromegaly: Quantitative Ultrasound of the Heel","volume":"10","author":"Kastelan","year":"2007","journal-title":"J Clin Densitom"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5421961","DOI":"10.1155\/2018\/5421961","article-title":"Hepatic Steatosis Index in Acromegaly: Correlation With Insulin Resistance Regardless of the Disease Control","volume":"2018","author":"Ciresi","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e00090","DOI":"10.1002\/edm2.90","article-title":"Hepatic Steatosis in Patients With Acromegaly","volume":"2","author":"Koutsou-Tassopoulou","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00643","article-title":"Association of Vitamin D Receptor Polymorphisms With Activity of Acromegaly, Vitamin D Status and Risk of Osteoporotic Fractures in Acromegaly Patients","volume":"10","author":"Jawiarczyk-Przybylowska","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0058-5","article-title":"A Consensus Statement on Acromegaly Therapeutic Outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5603\/EP.a2018.0093","article-title":"Diagnostics and Treatment of Acromegaly - Updated Recommendations of the Polish Society of Endocrinology","volume":"70","author":"Bolanowski","year":"2019","journal-title":"Endokrynol Pol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.14341\/probl200753437-41","article-title":"[Russian Consensus on the Diagnosis, Treatment, and Monitoring of Acromegalia (Draft)]","volume":"53","author":"Molitvoslovova","year":"2007","journal-title":"Probl Endokrinol (Mosk)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2020.0020","article-title":"Improvement of Acromegaly Control With Multimodal Therapy in Romania","volume":"71","author":"Marinescu","year":"2020","journal-title":"Endokrynol Pol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2298\/VSP200120036D","article-title":"The Place of Medical Treatment of Acromegaly in Serbia: Current Status","volume":"78","author":"Dokni\u0107","year":"2021","journal-title":"Vojnosanitetski Pregled"},{"key":"B38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5603\/EP.a2018.0080","article-title":"The Real Costs of Acromegaly: Analysis of Different Therapies","volume":"70","author":"Elbaum","year":"2019","journal-title":"Endokrynol Pol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0908-0","article-title":"Cost-Effectiveness of Acromegaly Treatments: A Systematic Review","volume":"21","author":"Leonart","year":"2018","journal-title":"Pituitary"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society Update to Acromegaly Management Guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00142","article-title":"High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study","volume":"102","author":"Giustina","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2480","article-title":"Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study","volume":"99","author":"Colao","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00931","article-title":"Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs","volume":"10","author":"Gadelha","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01979","article-title":"How to Position Pasireotide LAR Treatment in Acromegaly","volume":"104","author":"Coopmans","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1690-5","article-title":"Efficacy and Safety of Long-Acting Pasireotide in Patients With Somatostatin-Resistant Acromegaly: A Multicenter Study","volume":"62","author":"Shimon","year":"2018","journal-title":"Endocrine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02281","article-title":"Pegvisomant Improves Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies","volume":"104","author":"Feola","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0616","article-title":"Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY","volume":"179","author":"Buchfelder","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12020-018-1729-7","article-title":"Effectiveness and Safety of Pegvisomant: A Systematic Review and Meta-Analysis of Observational Longitudinal Studies","volume":"63","author":"Leonart","year":"2019","journal-title":"Endocrine"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0614-1","article-title":"Pegvisomant in Acromegaly: An Update","volume":"40","author":"Giustina","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0528","article-title":"Comparative Efficacy of Medical Treatment for Acromegaly: A Systematic Review and Network Meta-Analysis of Integrated Randomized Trials and Observational Studies","volume":"26","author":"Qiao","year":"2020","journal-title":"Endocr Pract"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0996","article-title":"Increasing Frequency of Combination Medical Therapy in the Treatment of Acromegaly With the GH Receptor Antagonist Pegvisomant","volume":"178","author":"Strasburger","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0784","article-title":"Fractionated Radiotherapy and Radiosurgery in Acromegaly: Analysis of 352 Patients From the German Acromegaly Registry","volume":"182","author":"Knappe","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy178","article-title":"Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study","volume":"84","author":"Ding","year":"2019","journal-title":"Neurosurgery"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02513.x","article-title":"Gamma Knife Radiosurgery for Acromegaly\u2013Long-Term Experience","volume":"64","author":"Je\u017ekova","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11102-017-0792-z","article-title":"Biochemical Investigations in Diagnosis and Follow Up of Acromegaly","volume":"20","author":"Schilbach","year":"2017","journal-title":"Pituitary"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00202","article-title":"Classification of Patients With GH Disorders May Vary According to the IGF-I Assay","volume":"102","author":"Mavromati","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14341\/probl10333","article-title":"[Epidemiology, Clinical Manifestations and Efficiency of Different Methods of Treatment of Acromegaly According to the United Russian Registry of Patients With Pituitary Tumors]","volume":"66","author":"Belaya","year":"2020","journal-title":"Probl Endokrinol (Mosk)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2017.0041","article-title":"Acromegaly Treatment in Romania. How Close are We to Disease Control","volume":"68","author":"Niculescu","year":"2017","journal-title":"Endokrynol Pol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2020-0171","article-title":"Medical Treatment Landscape for Active Acromegaly in a Pituitary Center in Israel","volume":"26","author":"Masri-Iraqi","year":"2020","journal-title":"Endocr Pract"},{"key":"B60","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s11102-017-0835-5","article-title":"Development of ACRODAT(\u00ae), a New Software Medical Device to Assess Disease Activity in Patients With Acromegaly","volume":"20","author":"van der Lely","year":"2017","journal-title":"Pituitary"},{"key":"B61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11102-015-0681-2","article-title":"SAGIT\u00ae: Clinician-Reported Outcome Instrument for Managing Acromegaly in Clinical Practice\u2013Development and Results From A Pilot Study","volume":"19","author":"Giustina","year":"2016","journal-title":"Pituitary"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-00977-5","article-title":"Staging and Managing Patients With Acromegaly in Clinical Practice: Baseline Data From the SAGIT\u00ae Validation Study","volume":"22","author":"Giustina","year":"2019","journal-title":"Pituitary"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-00986-4","article-title":"Development of a Novel Patient-Reported Measure for Acromegaly: The Acro-TSQ","volume":"22","author":"Fleseriu","year":"2019","journal-title":"Pituitary"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.816426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T07:36:33Z","timestamp":1645515393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.816426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":63,"alternative-id":["10.3389\/fendo.2022.816426"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.816426","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"article-number":"816426"}}